Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Oligonucleotide analysis by hydrophilic interaction liquid chromatography-mass spectrometry in the absence of ion-pair reagents.

Lobue PA, Jora M, Addepalli B, Limbach PA.

J Chromatogr A. 2019 Jun 21;1595:39-48. doi: 10.1016/j.chroma.2019.02.016. Epub 2019 Feb 7.

PMID:
30772056
2.

Detection of ribonucleoside modifications by liquid chromatography coupled with mass spectrometry.

Jora M, Lobue PA, Ross RL, Williams B, Addepalli B.

Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):280-290. doi: 10.1016/j.bbagrm.2018.10.012. Epub 2018 Nov 7. Review.

PMID:
30414470
3.

Improved application of RNAModMapper - An RNA modification mapping software tool - For analysis of liquid chromatography tandem mass spectrometry (LC-MS/MS) data.

Lobue PA, Yu N, Jora M, Abernathy S, Limbach PA.

Methods. 2019 Mar 1;156:128-138. doi: 10.1016/j.ymeth.2018.10.012. Epub 2018 Oct 24.

PMID:
30366097
4.

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.

Borisov AS, Bamrah Morris S, Njie GJ, Winston CA, Burton D, Goldberg S, Yelk Woodruff R, Allen L, LoBue P, Vernon A.

MMWR Morb Mortal Wkly Rep. 2018 Jun 29;67(25):723-726. doi: 10.15585/mmwr.mm6725a5.

5.

Differentiating Positional Isomers of Nucleoside Modifications by Higher-Energy Collisional Dissociation Mass Spectrometry (HCD MS).

Jora M, Burns AP, Ross RL, Lobue PA, Zhao R, Palumbo CM, Beal PA, Addepalli B, Limbach PA.

J Am Soc Mass Spectrom. 2018 Aug;29(8):1745-1756. doi: 10.1007/s13361-018-1999-6. Epub 2018 Jun 12.

6.

RNAModMapper: RNA Modification Mapping Software for Analysis of Liquid Chromatography Tandem Mass Spectrometry Data.

Yu N, Lobue PA, Cao X, Limbach PA.

Anal Chem. 2017 Oct 17;89(20):10744-10752. doi: 10.1021/acs.analchem.7b01780. Epub 2017 Oct 5.

PMID:
28942636
7.

Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.

LoBue PA, Mermin JH.

Lancet Infect Dis. 2017 Oct;17(10):e327-e333. doi: 10.1016/S1473-3099(17)30248-7. Epub 2017 May 8. Review.

8.

Role of the Health Department in Tuberculosis Prevention and Control-Legal and Public Health Considerations.

Jeffries C, Lobue P, Chorba T, Metchock B, Kashef I.

Microbiol Spectr. 2017 Mar;5(2). doi: 10.1128/microbiolspec.TNMI7-0034-2016. Review.

PMID:
28256190
9.

Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.

Scott C, Cavanaugh JS, Silk BJ, Ershova J, Mazurek GH, LoBue PA, Moonan PK.

Emerg Infect Dis. 2017 Mar;23(3):456-462. doi: 10.3201/eid2303.161916.

10.

In reply.

Castro KG, Marks SM, Hill AN, Chen MP, Miramontes R, Winston CA, LoBue PA.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):120-121. doi: 10.5588/ijtld.16.0708-2. No abstract available.

11.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.

12.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL.

Clin Infect Dis. 2017 Jan 15;64(2):e1-e33. doi: 10.1093/cid/ciw694. Epub 2016 Dec 8.

PMID:
27932390
13.

Zoonotic tuberculosis in human beings caused by Mycobacterium bovis-a call for action.

Olea-Popelka F, Muwonge A, Perera A, Dean AS, Mumford E, Erlacher-Vindel E, Forcella S, Silk BJ, Ditiu L, El Idrissi A, Raviglione M, Cosivi O, LoBue P, Fujiwara PI.

Lancet Infect Dis. 2017 Jan;17(1):e21-e25. doi: 10.1016/S1473-3099(16)30139-6. Epub 2016 Sep 30. Review.

PMID:
27697390
14.

Human Tuberculosis Caused by Mycobacterium bovis in the United States, 2006-2013.

Scott C, Cavanaugh JS, Pratt R, Silk BJ, LoBue P, Moonan PK.

Clin Infect Dis. 2016 Sep 1;63(5):594-601. doi: 10.1093/cid/ciw371. Epub 2016 Jun 13.

PMID:
27298329
15.

Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.

Castro KG, Marks SM, Chen MP, Hill AN, Becerra JE, Miramontes R, Winston CA, Navin TR, Pratt RH, Young KH, LoBue PA.

Int J Tuberc Lung Dis. 2016 Jul;20(7):926-33. doi: 10.5588/ijtld.15.1001.

16.

Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.

Miramontes R, Hill AN, Yelk Woodruff RS, Lambert LA, Navin TR, Castro KG, LoBue PA.

PLoS One. 2015 Nov 4;10(11):e0140881. doi: 10.1371/journal.pone.0140881. eCollection 2015.

17.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24. Review.

18.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

19.

Is it time to replace the tuberculin skin test with a blood test?

LoBue PA, Castro KG.

JAMA. 2012 Jul 18;308(3):241-2. doi: 10.1001/jama.2012.7511. No abstract available.

20.

Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.

Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ, Scarborough R, LoBue PA, Lardizabal AA, Daley CL, Reves RR, Bernardo J, Campbell BH, Whitworth WC, Mazurek GH.

PLoS One. 2011;6(11):e26545. doi: 10.1371/journal.pone.0026545. Epub 2011 Nov 21.

21.

Unexpected decline in tuberculosis cases coincident with economic recession - United States, 2009.

Winston CA, Navin TR, Becerra JE, Chen MP, Armstrong LR, Jeffries C, Yelk Woodruff RS, Wing J, Starks AM, Hales CM, Kammerer JS, Mac Kenzie WR, Mitruka K, Miner MC, Price S, Scavotto J, Cronin AM, Griffin P, LoBue PA, Castro KG.

BMC Public Health. 2011 Nov 7;11:846. doi: 10.1186/1471-2458-11-846.

22.

No rebound in tuberculosis in the United States in 2010.

Winston CA, Navin TR, Becerra JE, LoBue PA.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1272. doi: 10.5588/ijtld.11.0303. No abstract available.

23.

People aged above 65 treated for latent tuberculosis are at increased risk of admission for a hepatic event compared with untreated controls.

Lobue P.

Evid Based Med. 2011 Dec;16(6):169-70. doi: 10.1136/ebmed-2011-0014. Epub 2011 Jun 6. No abstract available.

PMID:
21646317
24.
25.

Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean.

de Kantor IN, LoBue PA, Thoen CO.

Int J Tuberc Lung Dis. 2010 Nov;14(11):1369-73.

PMID:
20937174
26.

Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.

LoBue PA, Enarson DA, Thoen TC.

Int J Tuberc Lung Dis. 2010 Oct;14(10):1226-32. Review.

PMID:
20843412
27.

Tuberculosis in humans and animals: an overview.

LoBue PA, Enarson DA, Thoen CO.

Int J Tuberc Lung Dis. 2010 Sep;14(9):1075-8.

PMID:
20819249
28.

Why has zoonotic tuberculosis not received much attention?

Thoen CO, LoBue PA, de Kantor I.

Int J Tuberc Lung Dis. 2010 Sep;14(9):1073-4. No abstract available.

PMID:
20819248
29.

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25.

30.

Treatment of latent tuberculosis infection: An update.

Lobue P, Menzies D.

Respirology. 2010 May;15(4):603-22. doi: 10.1111/j.1440-1843.2010.01751.x. Epub 2010 Apr 7. Review.

PMID:
20409026
31.

Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.

Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA.

Emerg Infect Dis. 2009 Oct;15(10):1556-61. doi: 10.3201/eid1510.090310. Review.

32.

Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006.

Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR.

Clin Infect Dis. 2009 Nov 1;49(9):1350-7. doi: 10.1086/605559.

PMID:
19793000
33.

Clinical diagnosis of tuberculosis by specialists and non-specialists.

Lam PK, Lobue PA, Catanzaro A.

Int J Tuberc Lung Dis. 2009 May;13(5):659-61.

PMID:
19383202
34.

Extensively drug-resistant tuberculosis.

LoBue P.

Curr Opin Infect Dis. 2009 Apr;22(2):167-73. Review.

PMID:
19283912
35.

Tuberculosis: a re-emerging disease in animals and humans.

Thoen CO, Lobue PA, Enarson DA, Kaneene JB, de Kantor IN.

Vet Ital. 2009 Jan-Mar;45(1):135-81.

36.

The molecular epidemiology of human and zoonotic Mycobacterium bovis: the intersection between veterinary medicine and public health.

Moonan PK, Chatterjee SG, Lobue PA.

Prev Vet Med. 2009 Mar 1;88(3):226-7. doi: 10.1016/j.prevetmed.2008.10.001. Epub 2008 Dec 18. No abstract available.

PMID:
19100639
37.

No man is an island: reducing diagnostic delays in undocumented foreign-born persons is needed to decrease the risk of tuberculosis transmission.

Cain KP, Mac Kenzie WR, Castro KG, LoBue PA.

Clin Infect Dis. 2008 Nov 15;47(10):1284-6. doi: 10.1086/592573. No abstract available.

PMID:
18834316
38.

Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005.

Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP, Crawford JT, Lobue PA.

Clin Infect Dis. 2008 Jul 15;47(2):168-75. doi: 10.1086/589240.

PMID:
18532886
39.

Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.

Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA.

Clin Infect Dis. 2007 Oct 1;45(7):837-45. Epub 2007 Aug 24.

PMID:
17806047
40.

Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.

Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, Rothel JS, Daniels LJ, Pascual FB, Shang N, Keep LW, LoBue PA.

Clin Infect Dis. 2007 Oct 1;45(7):826-36. Epub 2007 Aug 24.

PMID:
17806046
41.

Mycobacterium bovis tuberculosis: forgotten, but not gone.

Thoen CO, LoBue PA.

Lancet. 2007 Apr 14;369(9569):1236-1238. doi: 10.1016/S0140-6736(07)60572-8. No abstract available.

PMID:
17434381
42.

The importance of Mycobacterium bovis as a zoonosis.

Thoen C, Lobue P, de Kantor I.

Vet Microbiol. 2006 Feb 25;112(2-4):339-45. Epub 2006 Jan 18. Review.

PMID:
16387455
43.

Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2005 Dec 16;54(RR-15):49-55. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Dec 23;54(50):1288.

44.

Regioselective routes to disubstituted dibenzo crown ethers and their complexations.

Gibson HW, Wang H, Bonrad K, Jones JW, Slebodnick C, Zackharov LN, Rheingold AL, Habenicht B, Lobue P, Ratliff AE.

Org Biomol Chem. 2005 Jun 7;3(11):2114-21. Epub 2005 May 4.

PMID:
15917898
45.
46.

Inhaled tobramycin: not just for cystic fibrosis anymore?

Lobue PA.

Chest. 2005 Apr;127(4):1098-101. No abstract available.

PMID:
15821180
47.
48.
49.

Identification of a familial cluster of pulmonary Mycobacterium bovis disease.

LoBue PA, Betancourt W, Cowan L, Seli L, Peter C, Moser KS.

Int J Tuberc Lung Dis. 2004 Sep;8(9):1142-6.

PMID:
15455603
50.

Contact investigation for cases of pulmonary Mycobacterium bovis.

LoBue PA, LeClair JJ, Moser KS.

Int J Tuberc Lung Dis. 2004 Jul;8(7):868-72.

PMID:
15260279

Supplemental Content

Support Center